ישראל - עברית - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 90 mg - cinacalcet

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - gefitinib - טבליות מצופות פילם - gefitinib 250 mg - gefitinib

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 10 mg - lenalidomide

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 15 mg - lenalidomide

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 2.5 mg - lenalidomide

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 20 mg - lenalidomide

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 25 mg - lenalidomide

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 5 mg - lenalidomide

ישראל - עברית - Ministry of Health

taro international ltd, israel - lenalidomide - קפסולות - lenalidomide 7.5 mg - lenalidomide

ישראל - עברית - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob